Assessing a thyroid nodule

USG

First and second year — the floor first, then every step

A risk-stratification exercise with a published lexicon — the features are scored, not described freely, and size only matters after the score.

Orient first

  • This is a SCORING task, not a descriptive one. Composition, echogenicity, shape, margin and echogenic foci each contribute, and the total determines whether the nodule is sampled.
  • SIZE DOES NOT DETERMINE RISK. It determines the threshold at which a nodule of a given risk level is biopsied. A large spongiform nodule may need nothing; a small solid hypoechoic one with microcalcification may need sampling.
  • The most suspicious individual features are: solid composition, marked hypoechogenicity, TALLER-THAN-WIDE shape, irregular or lobulated margin, extrathyroidal extension, and punctate echogenic foci (microcalcification).
  • Comet-tail artefact within a cystic component is a colloid crystal and is REASSURING — it is not calcification, and confusing the two escalates a benign nodule.
  • Lexicons and their biopsy thresholds differ between systems and change between versions. State which system and which version you applied.

Acquire the study

  • High-frequency linear probe, 10–15 MHz; the patient supine with the neck extended on a pillow.
  • Scan the whole gland in transverse and longitudinal, then the nodule in both planes.
  • Measure TALLER-THAN-WIDE on the TRANSVERSE image — the anteroposterior dimension compared with the transverse one. Judging it on a longitudinal image is a different measurement and a common error.
  • Set the focal zone at the nodule and optimise gain against adjacent normal thyroid before calling anything hypoechoic.
  • Always include the cervical nodal levels — a suspicious node changes management more than the nodule score.

The manoeuvre

  • Describe COMPOSITION: cystic, spongiform, mixed cystic-solid, or solid.
  • Describe ECHOGENICITY against normal thyroid parenchyma AND against the strap muscle — marked hypoechogenicity means darker than strap muscle.
  • Assess SHAPE on the transverse image: taller-than-wide or not.
  • Assess MARGIN: smooth, ill-defined, lobulated or irregular, and look for extrathyroidal extension.
  • Assess ECHOGENIC FOCI: punctate (suspicious), macrocalcification, peripheral rim calcification, or comet-tail artefact (benign colloid).
  • Measure in three planes and give the largest dimension.
  • Examine ALL cervical nodal levels for rounded shape, loss of the fatty hilum, cystic change, calcification or peripheral vascularity.
  • Assign a category from a named system, state the version, and give the resulting recommendation.

What confirms it

  • A high-risk category is a conjunction of features — solid, markedly hypoechoic, taller-than-wide, irregular margin, punctate echogenic foci — not any single one.
  • A suspicious LYMPH NODE is more decisive than the nodule score and should be sampled in preference.

What licenses you to exclude it

  • ⚠️ Ultrasound stratifies risk; it does not exclude malignancy. A low-risk category means a low probability, not none, and the report should say what follow-up that implies.
  • A purely cystic or spongiform nodule is reliably benign and needs no sampling — that is the one genuinely reassuring appearance.
  • Ultrasound cannot assess a substernal extension; recommend cross-sectional imaging when the lower pole is not seen.

The classic misread

  • Measuring taller-than-wide on the longitudinal image.
  • Calling comet-tail artefact microcalcification, which escalates a benign colloid nodule.
  • Judging "markedly hypoechoic" without comparing against strap muscle.
  • Scoring the nodule and never examining the nodes.

Reference values

Each value carries the caveat that keeps it from being misused. Normal limits and diagnostic criteria are kept apart on purpose: a disease cut-off read as a normal range is the more dangerous mistake.

Normal limits

  • Thyroid · lobe AP diameterup to 20 mm

    AP diameter is the dimension that discriminates; length varies widely with habitus.

    USG

  • Thyroid · Total gland volume

    up to approximately 18 mL in women and 25 mL in men (commonly quoted adult ceilings)

    Sum of both lobes by the ellipsoid formula (length × width × depth × 0.52 per lobe), excluding the isthmus unless it is enlarged.

    Volume tracks body size and iodine status — reference ranges from iodine-deficient regions run larger, so these ceilings are conventions rather than universal biology.

    USG

Diagnostic criteria

  • Thyroid nodule · ACR TI-RADS FNA size thresholds

    FNA is recommended at 2.5 cm or more for TR3, 1.5 cm or more for TR4, and 1 cm or more for TR5 nodules

    The size thresholds are meaningless without the points-based TR category — score the nodule first. Other systems (EU-TIRADS, K-TIRADS, ATA) use different thresholds; name the system in the report. Versioned criterion — verify against the current edition before clinical use.

    USG

  • Thyroid nodule · Composition categories in ACR TI-RADS

    a named lexicon: cystic / spongiform / mixed cystic-solid / solid — composition is a POINTS input, not a diagnosis

    Spongiform and purely cystic nodules score differently from solid ones — mis-calling a spongiform nodule "solid" is how over-biopsy starts. Name the system (ACR vs EU-TIRADS vs K-TIRADS). Versioned criterion — verify against the current edition before clinical use.

    USG

See it on real cases

Direct links to Radiopaedia — the reference article and worked cases with their images. Each opens on Radiopaedia.

Key papers

Reviews and guidelines from RSNA, ESR and related journals. Each opens at its DOI.

  1. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee ↗Tessler FN, Middleton WD, Grant EG, et al. · Journal of the American College of Radiology 2017ACR · PubMed
  2. Thyroid Imaging Reporting and Data System (TI-RADS): A User's Guide ↗Tessler FN, Middleton WD, Grant EG · Radiology 2018RSNA · PubMed
  3. International Expert Consensus on US Lexicon for Thyroid Nodules ↗Durante C, Hegedüs L, Na DG, et al. · Radiology 2023RSNA · PubMed
  4. ACR TI-RADS: Pitfalls, Solutions, and Future Directions ↗Tappouni RR, Itri JN, McQueen TS, et al. · RadioGraphics 2019RSNA · PubMed

More searches

More in Neuro and head & neck